z-logo
Premium
Plasma kallikrein clearance by the liver of chronic carbon tetrachloride‐treated rats
Author(s) -
TOLEDO CARLOS F.,
KOUYOUMDJIAN MARIA,
LANZONI VALÉRIA P.,
BORGES DURVAL R.
Publication year - 1995
Publication title -
journal of gastroenterology and hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.214
H-Index - 130
eISSN - 1440-1746
pISSN - 0815-9319
DOI - 10.1111/j.1440-1746.1995.tb01072.x
Subject(s) - carbon tetrachloride , medicine , cirrhosis , albumin , clearance rate , ascites , endocrinology , liver function , chemistry , organic chemistry
We have previously reported that the endocytosis of rat plasma kallikrein (RPK) by hepatocytes is a calcium‐independent and beta‐galactoside‐dependent mechanism. We now report the clearance of RPK by the liver of four groups of rats: normal, inflamed (48 h ex‐turpentine) and two groups chronically treated with CCl 4 (52 mg/kg per week, intragastrically, for 9‐12 weeks). Each liver was isolated, exsanguinated and perfused at 37°C with 30 mL of BSA‐Krebs‐Henseleit‐bicarbonate medium containing 10 nmol/L RPK. Although all rats received the same mild CCl 4 treatment, the liver histology showed that they evolved either to severe hepatitis (serum alanine aminotransferase [ALT] 4852 ± 885 U/L, parenchymatous necrosis in the perivenous region) or to compensated cirrhosis (serum ALT 209 ± 42 U/L, vigorous fibrous encircling regeneration nodules); neither jaundice nor ascites was noted. The results show that serum albumin was not altered among the groups and that: the acute‐phase response by itself (inflamed group) increased RPK clearance rate (3.01 ± 0.59 mL/min) as compared with the normal group (1.85 ± 0.14 mL/min); the CCl 4 treatment, although induced an acute‐phase response, decreased ( P < 0.01) RPK clearance rates (0.80 ± 0.11 mL/min hepatitis group and 0.98 ± 0.10 mL/min cirrhosis group). These findings suggest that the hepatic clearance rate of plasma kallikrein is an early indicator of liver injury.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here